Making clinical trials more welcoming for everyone
Leveraging discrete choice experiments to increase participant diversity in future clinical trials
This project helps us understand what makes people from diverse backgrounds want to join clinical trials, especially for conditions like adult-onset diabetes.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rush University Medical Center NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11059066 on NIH RePORTER |
What this research studies
Many people from different backgrounds, including various racial and ethnic groups or those with lower income, are not often included in clinical trials. This makes it harder to find new ways to help everyone with conditions like adult-onset diabetes. This project uses a special survey method called a "discrete choice experiment" to ask people what features of a clinical trial would make them more likely to participate. We want to learn what matters most to different groups, such as access to care, incentives, or how much time a trial takes. The goal is to find better ways to design trials so that more people feel comfortable and willing to join.
Who could benefit from this research
Good fit: This project is looking for insights from people who might consider joining future clinical trials, particularly those from groups often underrepresented in research.
Not a fit: Patients who are not interested in providing feedback on clinical trial design or who do not belong to underrepresented groups may not directly benefit from this specific project.
Why it matters
Potential benefit: If successful, this work could lead to clinical trials that better represent all patients, ensuring new treatments are effective for a wider range of people.
How similar studies have performed: While some studies have identified general motivations for trial participation, this project uses a specific method to prioritize attributes for diverse groups, which is a more novel approach.
Where this research is happening
Chicago, United States
- Rush University Medical Center — Chicago, United States (Active)
Researchers
- Principal investigator: Crane, Melissa Marie — Rush University Medical Center
- Study coordinator: Crane, Melissa Marie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.